StockData
Ceribell, Inc. logo

Ceribell, Inc. (CBLL) stock

CBLLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30137% above fair value
$25.63−0.34 (-1.31%)

Close on Nov 18, 2026Market cap $983.63MP/E –Yield –

Ceribell gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Ceribell's gross profit for the twelve months ending Jun 30, 2026 was $90.65M, up 33.4% year over year. For fiscal 2025 it was $78.27M, up 37.9% from the year before.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$78.27M+37.9%
FY2024Dec 31, 2024$56.75M+48.7%
FY2023Dec 31, 2023$38.16M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$25.94M+38.8%
Q1 FY2026Mar 31, 2026$23.12M+28.4%
Q4 FY2025Dec 31, 2025$21.64M+33.3%
Q3 FY2025Sep 30, 2025$19.94M+32.8%
Q2 FY2025Jun 30, 2025$18.68M+42.0%
Q1 FY2025Mar 31, 2025$18.01M+45.9%
Q4 FY2024Dec 31, 2024$16.24M+46.1%
Q3 FY2024Sep 30, 2024$15.01M+54.3%
Q2 FY2024Jun 30, 2024$13.16M–
Q1 FY2024Mar 31, 2024$12.34M–
Q4 FY2023Dec 31, 2023$11.12M–
Q3 FY2023Sep 30, 2023$9.73M–

More Ceribell figures

See a number that looks wrong?